Literature DB >> 3260184

The Y chromosome from autoimmune BXSB/MpJ mice induces a lupus-like syndrome in (NZW x C57BL/6)F1 male mice, but not in C57BL/6 male mice.

S Izui1, M Higaki, D Morrow, R Merino.   

Abstract

The Y chromosome of the BXSB mouse has been shown to be responsible for the acceleration of lupus-like autoimmune syndrome in inbred BXSB mice and in their F1 hybrids with NZB or NZW mice. To further define the role of this as yet unidentified gene linked to the BXSB Y chromosome, designated Yaa (Y chromosome-linked autoimmune acceleration), the Y chromosome was transferred from the BXSB strain to nonautoimmune C57BL/6 (B6) mice. The effect of the Yaa gene on the autoantibody formation and the development of glomerulonephritis was investigated in B6 mice and in their F1 hybrids with NZW mice. The presence of the BXSB Y chromosome was not able to induce significant autoimmune responses in B6 mice. However, (NZW x B6)F1 males bearing the BXSB Y chromosome developed a severe lupus-like autoimmune syndrome, as documented by the production of anti-DNA antibodies and gp70-anti-gp70 immune complexes and the development of lethal lupus nephritis. Both sexes of (NZW x B6)F1 hybrids without the BXSB Y chromosome were essentially normal. Our results suggest that (a) the BXSB Y chromosome by itself is not sufficient to initiate autoimmune responses in nonautoimmune B6 mice, and (b) it is able to induce autoimmune responses in mice potentially capable of developing the disease, but whose autosomal abnormality by itself is not sufficient to develop autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3260184     DOI: 10.1002/eji.1830180612

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  30 in total

Review 1.  The lupus-prone BXSB strain: the Yaa gene model of systemic lupus erythematosus.

Authors:  R Merino; L Fossati; S Izui
Journal:  Springer Semin Immunopathol       Date:  1992

Review 2.  Mouse Y chromosome.

Authors:  C E Bishop
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

Review 3.  Genetics of SLE in mice.

Authors:  Dwight H Kono; Argyrios N Theofilopoulos
Journal:  Springer Semin Immunopathol       Date:  2006-09-14

4.  Distinct roles of CSF-1 isoforms in lupus nephritis.

Authors:  Julia Menke; Yasunori Iwata; Whitney A Rabacal; Ranu Basu; E Richard Stanley; Vicki R Kelley
Journal:  J Am Soc Nephrol       Date:  2011-09-01       Impact factor: 10.121

5.  A Tlr7 translocation accelerates systemic autoimmunity in murine lupus.

Authors:  Srividya Subramanian; Katalin Tus; Quan-Zhen Li; Andrew Wang; Xiang-Hong Tian; Jinchun Zhou; Chaoying Liang; Guy Bartov; Lisa D McDaniel; Xin J Zhou; Roger A Schultz; Edward K Wakeland
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-15       Impact factor: 11.205

6.  CD8+ T regulatory cells express the Ly49 Class I MHC receptor and are defective in autoimmune prone B6-Yaa mice.

Authors:  Hye-Jung Kim; Xuan Wang; Soroosh Radfar; Thomas J Sproule; Derry C Roopenian; Harvey Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-13       Impact factor: 11.205

7.  VISA is required for B cell expression of TLR7.

Authors:  Liang-Guo Xu; Lei Jin; Bi-Cheng Zhang; Linda J Akerlund; Hong-Bing Shu; John C Cambier
Journal:  J Immunol       Date:  2011-11-21       Impact factor: 5.422

Review 8.  Mechanisms of genetic control of murine systemic lupus erythematosus.

Authors:  S Izui; R Merino; M Iwamoto; L Fossati
Journal:  Springer Semin Immunopathol       Date:  1994

9.  Effect of cyclophosphamide on lymphokine production in MRL/lpr.Yaa mice.

Authors:  H Kamada; Y Takaoka; K Kitagaki; H Nagai
Journal:  Inflamm Res       Date:  1995-11       Impact factor: 4.575

10.  TLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus.

Authors:  Pui Y Lee; Yutaro Kumagai; Yi Li; Osamu Takeuchi; Hideo Yoshida; Jason Weinstein; Erinn S Kellner; Dina Nacionales; Tolga Barker; Kindra Kelly-Scumpia; Nico van Rooijen; Himanshu Kumar; Taro Kawai; Minoru Satoh; Shizuo Akira; Westley H Reeves
Journal:  J Exp Med       Date:  2008-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.